Canada Markets closed
  • S&P/TSX

    20,758.34
    +17.94 (+0.09%)
     
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • DOW

    33,926.01
    -127.89 (-0.38%)
     
  • CAD/USD

    0.7462
    -0.0005 (-0.0694%)
     
  • CRUDE OIL

    73.55
    +0.16 (+0.22%)
     
  • BTC-CAD

    30,728.62
    -756.49 (-2.40%)
     
  • CMC Crypto 200

    526.03
    -10.83 (-2.02%)
     
  • GOLD FUTURES

    1,889.80
    +13.20 (+0.70%)
     
  • RUSSELL 2000

    1,985.53
    -15.69 (-0.78%)
     
  • 10-Yr Bond

    3.5320
    +0.1360 (+4.00%)
     
  • NASDAQ futures

    12,571.50
    -52.50 (-0.42%)
     
  • VOLATILITY

    18.33
    -0.40 (-2.14%)
     
  • FTSE

    7,901.80
    +81.64 (+1.04%)
     
  • NIKKEI 225

    27,734.58
    +225.12 (+0.82%)
     
  • CAD/EUR

    0.6908
    -0.0005 (-0.07%)
     

Cerus Third Quarter 2022 Earnings: US$0.048 loss per share (vs US$0.072 loss in 3Q 2021)

Cerus (NASDAQ:CERS) Third Quarter 2022 Results

Key Financial Results

  • Revenue: US$39.6m (up 9.5% from 3Q 2021).

  • Net loss: US$8.48m (loss narrowed by 32% from 3Q 2021).

  • US$0.048 loss per share (improved from US$0.072 loss in 3Q 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cerus Earnings Insights

Looking ahead, revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Before we wrap up, we've discovered 2 warning signs for Cerus that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here